Real Talk on Remote Leadership with Nick Klingensmith

In the most recent episode of our podcast, The Life Science Rundown, The FDA Group's Nick Capman sat down with Nick Klingensmith, a four-time cancer survivor, motivational speaker, and mindset coach. They discuss the challenges of remote work, especially the disconnect between leadership, management, and frontline employees, and how it affects company culture and employee engagement.

Apple | Spotify | YouTube | Web + Others

Key points discussed include:

• Klingensmith's journey from sales in the telecom and logistics industries to becoming a motivational speaker and coach, emphasizing resilience and overcoming obstacles.

• The fundamental disconnect in remote work environments, where leaders fail to engage effectively with their teams, leading to feelings of isolation and disconnection among employees.

• The perception gap between managers and employees regarding communication and engagement, with many employees feeling overlooked unless there's a problem.

• The need for leaders to adapt to remote work by overcommunicating, setting clear expectations, and fostering genuine connections with their teams.

• Klingensmith’s critique of the lack of training for managers on how to lead remote teams effectively, emphasizing the need for mentorship, accountability, and proactive communication.

• The importance of understanding the distinction between micromanagement and accountability, and the role of empathy and vulnerability in leadership.

Klingensmith provides actionable advice for building a resilient remote workforce, such as staying present, focusing on what can be controlled, and being authentic and vulnerable as a leader. He also highlights his upcoming book, "Selling Inspired," aimed at sales professionals, and shares where he can be found online for speaking engagements.

Nick helps remote sales teams and leaders develop a warrior mindset and overcome self-sabotage, fears, and excuses to achieve success. With 20 years of sales experience and 10 years of executive leadership, he’s passionate about driving revenue growth and developing people. He collaborates cross-functionally to identify opportunities, author unique value propositions, and analyze gaps to drive stronger performance.

---

Not a paid subscriber yet?

Here’s what you’re missing:

• 🔒 FDA Revives Its Proposed Quality Metrics for Pharma and Clarifies Device Cybersecurity Recommendations + Warning Letter Breakdown

• 🔒 Revisions to Q9(R1) Quality Risk Management, Getting "Recall Ready" + Warning Letter Breakdown

• 🔒 Reviewing RMPs Against FDA's Drug Shortage Guidance, Inside FDA's Device VIP + Warning Letter Breakdown

• 🔒 Reporting CMC Post-Approval Changes, Proactively Addressing the Root Causes of Medical Device Recalls + Warning Letter Breakdown

• 🔒 Alternative cGMP Compliance Methods for Combo Products, Device Production and Quality System Software Assurance + Warning Letter Breakdown

• 🔒 Revised Compliance Guides for PAIs and GMP Drug Inspections, New Guidances On Device Post-Approval Studies, Postmarket Surveillance + Warning Letter Breakdown

• 🔒 Implementing ICH Q14’s Enhanced Approach to Analytical Method Development, FDA's Proposed Framework for Human Factor Info in Device Submissions + Warning Letter Breakdown

• 🔒 FDA Finalizes Guidance on REMS Format and Content, Preparing for Expanded Device Inspection Authority + Warning Letter Breakdown

• 🔒 “The Compliance Issue” Addressing the Top-Cited CFRs to Pharma and Device Firms + Warning Letter Breakdown

• 🔒 Applying FDA's Final ICH Q13 Continuous Manufacturing Guidance, Preparing for October's eSTAR Requirement + Warning Letter Breakdown

• 🔒 FDA's Draft Guidance on OTC Drug Submissions Content/Format, PCCPs for AI/ML Devices + Warning Letter Breakdown

Upgrade here to unlock all of these issues and new ones »

---

The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates.

Need expert help planning and executing compliance projects or connecting with a quality and compliance professional? Get in touch with us. If we haven’t worked together yet, watch our explainer video below or head to our company introduction page to see if we could help you execute your projects now or in the future.

Our service areas:

Quality Assurance | Regulatory Affairs | Clinical Operations | Commissioning, Qualification, and Validation | Chemistry, Manufacturing, and Controls (CMC) | Expert Witness

Our engagement models:

Consulting Projects | Staff Augmentation | FTE Recruitment | Functional Service Program

Our podcast:

Apple | Spotify | YouTube | Web + Others